{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T03:30:53Z","timestamp":1783999853248,"version":"3.55.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.schres.2010.12.007","type":"journal-article","created":{"date-parts":[[2011,1,10]],"date-time":"2011-01-10T04:05:26Z","timestamp":1294632326000},"page":"110-116","source":"Crossref","is-referenced-by-count":71,"title":["Schizophrenia patients at higher risk of diabetes, hypertension and hyperlipidemia: A population-based study"],"prefix":"10.1016","volume":"126","author":[{"given":"Chun-Hui","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Shu","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Ching","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Ni","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Chang","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsien-Yuan","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fung-Chang","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2010.12.007_bb0005","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.schres.2006.09.025","article-title":"Cardiovascular and metabolic risk in outpatients with schizophrenia treated with antipsychotics: results of the CLAMORS Study","volume":"90","author":"Bobes","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2010.12.007_bb0010","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.schres.2009.12.016","article-title":"Prevalence of cardiovascular risk factors and disease in people with schizophrenia: a population-based study","volume":"117","author":"Bresee","year":"2010","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2010.12.007_bb0015","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1192\/bjp.171.6.502","article-title":"Excess mortality of schizophrenia: a meta-analysis","volume":"171","author":"Brown","year":"1997","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2010.12.007_bb0020","series-title":"Six Countries, Six Reform Models: The Health Reform Experience of Israel, the Netherlands, New Zealand, Singapore, Switzerland and Taiwan","first-page":"71","article-title":"Taiwan's National Health Insurance system: high value for the dollar","author":"Cheng","year":"2009"},{"key":"10.1016\/j.schres.2010.12.007_bb0025","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.schres.2009.04.003","article-title":"Prevalence of diabetes in patients with schizophrenia in Taiwan: a population-based National Health Insurance study","volume":"111","author":"Chien","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2010.12.007_bb0030","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1177\/070674370404901106","article-title":"Characterizing coronary heart disease risk in chronic schizophrenia: high prevalence of the metabolic syndrome","volume":"49","author":"Cohn","year":"2004","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.schres.2010.12.007_bb0035","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.schres.2005.12.855","article-title":"Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication","volume":"83","author":"De Hert","year":"2006","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2010.12.007_bb0040","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.schres.2008.01.028","article-title":"Typical and atypical antipsychotics differentially affect long-term incidence rates of the metabolic syndrome in first-episode patients with schizophrenia: a retrospective chart review","volume":"101","author":"De Hert","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2010.12.007_bb0045","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/00005053-199908000-00006","article-title":"The association of medical comorbidity in schizophrenia with poor physical and mental health","volume":"187","author":"Dixon","year":"1999","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.schres.2010.12.007_bb0050","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/oxfordjournals.schbul.a033504","article-title":"Prevalence and correlates of diabetes in national schizophrenia samples","volume":"26","author":"Dixon","year":"2000","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2010.12.007_bb0055","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1001\/jama.288.14.1723","article-title":"Prevalence and trends in obesity among US adults: 1999\u20132000","volume":"288","author":"Flegal","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.schres.2010.12.007_bb0060","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4088\/JCP.v66n0205","article-title":"Medical morbidity and mortality in schizophrenia: guidelines for psychiatrists","volume":"66","author":"Goff","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2010.12.007_bb0065","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/01.CIR.0000111245.75752.C6","article-title":"Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute\/American Heart Association conference on scientific issues related to definition","volume":"109","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.schres.2010.12.007_bb0070","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/01.yic.0000188215.84784.17","article-title":"High prevalence of the metabolic syndrome among a Swedish cohort of patients with schizophrenia","volume":"21","author":"Hagg","year":"2006","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2010.12.007_bb0075","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.ahj.2005.02.007","article-title":"Schizophrenia and increased risks of cardiovascular disease","volume":"150","author":"Hennekens","year":"2005","journal-title":"Am. Heart J."},{"key":"10.1016\/j.schres.2010.12.007_bb0080","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1136\/hrt.2006.110171","article-title":"Inequalities in the primary care of patients with coronary heart disease and serious mental health problems: a cross sectional study","volume":"93","author":"Hippisley-Cox","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.schres.2010.12.007_bb0085","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1600-0447.2009.01401.x","article-title":"Prevalence of metabolic syndrome among patients with schizophrenia or schizoaffective disorder in Taiwan","volume":"120","author":"Huang","year":"2009","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2010.12.007_bb0090","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4088\/PCC.v07n0307","article-title":"The relation between body fat distribution and cardiovascular risk factors in patients with schizophrenia: a cross-sectional pilot study","volume":"7","author":"Kato","year":"2005","journal-title":"Prim. Care Companion J. Clin Psychiatry"},{"key":"10.1016\/j.schres.2010.12.007_bb0095","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1080\/07853890410031849","article-title":"Epidemiology and treatment of the metabolic syndrome","volume":"36","author":"Laaksonen","year":"2004","journal-title":"Ann. Med."},{"key":"10.1016\/j.schres.2010.12.007_bb0190","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.schres.2010.12.007_bb0100","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.schres.2007.12.485","article-title":"An increased risk of stroke among young schizophrenia patients","volume":"101","author":"Lin","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2010.12.007_bb0105","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.schres.2005.07.014","article-title":"Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III","volume":"80","author":"McEvoy","year":"2005","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2010.12.007_bb0110","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1001\/jama.289.1.76","article-title":"Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001","volume":"289","author":"Mokdad","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.schres.2010.12.007_bb0115","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0140-6736(89)91392-5","article-title":"Family history of type 2 diabetes in schizophrenic patients","volume":"1","author":"Mukherjee","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.schres.2010.12.007_bb0120","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0010-440X(96)90054-1","article-title":"Diabetes mellitus in schizophrenic patients","volume":"37","author":"Mukherjee","year":"1996","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.schres.2010.12.007_bb0125","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.schres.2006.06.026","article-title":"Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline","volume":"86","author":"Nasrallah","year":"2006","journal-title":"Schizophr. Res."},{"issue":"Suppl 4","key":"10.1016\/j.schres.2010.12.007_bb0130","first-page":"8","article-title":"Antipsychotic medications: metabolic and cardiovascular risk","volume":"68","author":"Newcomer","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2010.12.007_bb0135","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1177\/070674379103600401","article-title":"Mortality in a cohort of patients with schizophrenia: a record linkage study","volume":"36","author":"Newman","year":"1991","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.schres.2010.12.007_bb0140","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1471-244X-8-84","article-title":"Relative risk of diabetes, dyslipidaemia, hypertension and the metabolic syndrome in people with severe mental illnesses: systematic review and meta-analysis","volume":"8","author":"Osborn","year":"2008","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.schres.2010.12.007_bb0145","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1503\/cmaj.051455","article-title":"A comprehensive view of sex-specific issues related to cardiovascular disease","volume":"176","author":"Pilote","year":"2007","journal-title":"Can. Med. Assoc. J."},{"key":"10.1016\/j.schres.2010.12.007_bb0150","doi-asserted-by":"crossref","first-page":"559","DOI":"10.4088\/JCP.v66n0503","article-title":"A 4-fold risk of metabolic syndrome in patients with schizophrenia: the Northern Finland 1966 Birth Cohort Study","volume":"66","author":"Saari","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2010.12.007_bb0155","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.diabet.2007.01.003","article-title":"Abnormal glucose metabolism in patients treated with antipsychotics","volume":"33","author":"Scheen","year":"2007","journal-title":"Diab. Metab."},{"key":"10.1016\/j.schres.2010.12.007_bb0160","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1176\/appi.ajp.2008.08050756","article-title":"Double-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizo-affective disorder: findings from the treatment of early-onset schizophrenia spectrum disorders (TEOSS) study","volume":"165","author":"Sikich","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2010.12.007_bb0165","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1192\/bjp.bp.107.037184","article-title":"First- v. second-generation antipsychotics and risk for diabetes in schizophrenia: systematic review and meta-analysis","volume":"192","author":"Smith","year":"2008","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2010.12.007_bb0170","doi-asserted-by":"crossref","first-page":"167","DOI":"10.4088\/JCP.v66n0203","article-title":"Obesity and associated complications in patients with severe mental illnesses: a cross-sectional survey","volume":"66","author":"Susce","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2010.12.007_bb0175","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.4088\/JCP.v68n0711","article-title":"Metabolic syndrome among persons with schizophrenia and other psychotic disorders in a general population survey","volume":"68","author":"Suvisaari","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2010.12.007_bb0180","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/sj.ijo.0801840","article-title":"Increased visceral fat distribution in drug-na\u00efve and drug free patients with schizophrenia","volume":"26","author":"Thakore","year":"2002","journal-title":"Int. J. Obes. Relat. Metabol. Disord."},{"issue":"8","key":"10.1016\/j.schres.2010.12.007_bb0185","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1111\/j.1742-1241.2007.01416.x","article-title":"Metabolic side effects of antipsychotic medication","volume":"61","author":"Tschoner","year":"2007","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.schres.2010.12.007_bb0195","article-title":"Metabolic side effects of antipsychotic medication","author":"Warner","year":"1995","journal-title":"World Health Organization, Geneva, Switzerland"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996410016816?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996410016816?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T14:47:38Z","timestamp":1559918858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996410016816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":39,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0920996410016816"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2010.12.007","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}